Transcatheter Treatment Market 2019 ABBOTT LABORATORIES BIOTRONIK BOSTON SCIENTIFIC CORP. BRACCO SPA BRAILE BIOMÉDICA CARDIAC DIMENSIONS INC. CEPHEA VALVE TECHNOLOGIES INC. COLIBRI HEART VALVE LLC DIRECT FLOW MEDICAL INC. EDWARDS LIFESCIENCES CORP. GORMA

Summary
The global market for transcatheter treatment devices was worth nearly REDACTED in 2017. The market is expected to reach nearly REDACTED in 2018 and approximately REDACTED by 2023, increasing at a compound annual growth rate (CAGR) of REDACTED from 2018 through 2023. This high growth is fueled by increasing acceptance of transcatheter procedures (e.g., TAVR/TAVI and TMVR/TMVI) and increasing diagnosis of heart valve disease (e.g., aortic stenosis, mitral regurgitation, etc.) worldwide.

Request a Sample of this Report @ https://www.orbisresearch.com/contacts/request-sample/2676894

In 2017, the U.S. accounted for REDACTED of the global market, or REDACTED. The U.S. market should approach nearly REDACTED in 2018 and reach REDACTED by 2023, increasing at a CAGR of REDACTED from 2018 through 2023. Regionally, the U.S. is expected to maintain dominance in the global market of transcatheter treatment devices. Those wishing to invest in the transcatheter treatment devices market ought to strongly consider high-growth areas such as transcatheter aortic valve repair (TAVR), transcatheter mitral valve implantation (TMVI), and transcatheter mitral valve repair (TMVR) devices and technologies. The market is growing primarily due to the growing geriatric population, increasing
prevalence of chronic diseases, continuous technological advancements, increasing adoption of transcatheter techniques, and positive reimbursement and other healthcare reforms.

Report Scope:
Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR, and TMVI. Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases. The format of this study includes the following -
- Detailed description, including demographics and cost burden, of heart valve diseases (e.g., valvular stenosis and regurgitation) and transcatheter procedure approaches (e.g., transfemoral, transapical and transaortic.)
- Detailed description and analysis of transcatheter treatments devices including TAVR, TAVI, TMVR, and TMVI devices.
- Market characterization, unmet need, market size, and segmentation (by region and treatment).
- Market drivers and restraints.
- Detailed market projections through 2023.
- Competition and market shares.
- Key marketed and pipeline (R&D) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions on the future of transcatheter treatment.
- Profiles of market participants and associations.

Browse the Full Report @ https://www.orbisresearch.com/reports/index/transcatheter-treatment-procedures-and-heart-valve-market

Report Includes:

- 28 data tables and 25 additional tables
- An overview of the global market for transcatheter treatment technologies
- Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Analyses of the market by procedure segments, treatment approaches, and by region
- Detailed market sizing and analyses of the various transcatheter devices and technologies in use or under development
- Description of qualitative and quantitative factors that are driving the global market
- Description of key marketed and pipeline devices and technologies
- Profiles of major companies of the industry including, Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., Vascular Innovations Co. Ltd. and Valcare Inc.

Make an enquiry before buying this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/2676894

Companies Mentioned:
ABBOTT LABORATORIES
BIOTRONIK
BOSTON SCIENTIFIC CORP.
BRACCO SPA
BRAILE BIOMÉDICA
CARDIAC DIMENSIONS INC.
CEPHEA VALVE TECHNOLOGIES INC.
COLIBRI HEART VALVE LLC
DIRECT FLOW MEDICAL INC.
EDWARDS LIFESCIENCES CORP.
GORMAN CARDIOVASCULAR RESEARCH GROUP
HANSEN MEDICAL INC. (SUBSIDIARY OF AURIS HEALTH INC.)
HIGHLIFE SAS
JENAVALVE TECHNOLOGY INC.
LABORATORIES INVALV
LIVANOVA PLC
LONESTAR HEART INC.
MEDTRONIC INC.
MICRO INTERVENTIONAL DEVICES INC.
MICROPORT SCIENTIFIC
MITRAGEN INC.
MITRAL HEAL LTD.
MITRALIGN INC.
MITRALIX LTD.
MITRALTECH LTD.
MITRASSIST LTD.
MITRICARES SAS
MVRX INC.
NAKOSTECH SARL
NAVIGATE CARDIAC STRUCTURES INC.
NEOVASC INC.
NEW VALVE TECHNOLOGY (NVT) AG
SINO MEDICAL SCIENCE TECHNOLOGY INC.
ST. JUDE MEDICAL INC. (SUBSIDIARY OF ABBOTT LABORATORIES)
TAU-PNU MEDICAL CO. LTD.
THUBRIKAR AORTIC VALVE INC.
TRANSCATHETER TECHNOLOGIES GMBH
TRANSMURAL SYSTEMS
VALCARE INC.
VALVEXCHANGE INC.
VASCULAR INNOVATIONS CO. LTD.
VENUS MEDTECH INC.

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91206410101

This release was published on openPR.